Expertise in
4
conditions

Dr. Stephen D. Silberstein

Neurology
Headache Center
900 Walnut St Ste 200, 
Philadelphia, PA 
Expertise in
4
conditions
Headache Center
900 Walnut St Ste 200, 
Philadelphia, PA 

Overview

Stephen Silberstein is a Neurologist practicing medicine in Philadelphia, Pennsylvania.

Dr. Silberstein is highly rated in 4 conditions, according to our data. His clinical expertise encompasses Migraine, Headache, Cluster Headache, and Migraine with Brainstem Aura.

He is actively involved in clinical research, co-authoring 235 peer reviewed articles and participating in 6 clinical trials.

Specialties

Neurology

Licenses

Psychiatry & Neurology in PA

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Partners Plans
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE SNP
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO

Locations

Headache Center
900 Walnut St Ste 200, Philadelphia, PA 19107

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

6 Clinical Trials

A 12-month Prospective, Randomized, Interventional, Global, Multi-center, Active-controlled Study Comparing Sustained Benefit of Two Treatment Paradigms (AMG334 qm vs. Oral Prophylactics) in Adult Episodic Migraine Patients
A 12-month Prospective, Randomized, Interventional, Global, Multi-center, Active-controlled Study Comparing Sustained Benefit of Two Treatment Paradigms (AMG334 qm vs. Oral Prophylactics) in Adult Episodic Migraine Patients
Enrollment Status: Completed
Publish Date: November 18, 2023
Intervention Type: Drug
Study Drugs: Erenumab, Oral Prophylactic
Study Phase: Phase 4
A Randomized, Double-Blind, Placebo-Controlled, Add-on Therapy Study of Xeomin (Incobotulinumtoxina) Versus Placebo in the Treatment of Trigeminal Neuralgia
A Randomized, Double-Blind, Placebo-Controlled, Add-on Therapy Study of Xeomin (Incobotulinumtoxina) Versus Placebo in the Treatment of Trigeminal Neuralgia
Enrollment Status: Terminated
Publish Date: June 28, 2023
Intervention Type: Biological, Other
Study Phase: Phase 2
A Phase 2 Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches
A Phase 2 Safety and Efficacy Study of NPS 1776 for the Acute Treatment of Migraine Headaches
Enrollment Status: Completed
Publish Date: June 03, 2021
Intervention Type: Drug
Study Phase: Phase 2
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of : Galcanezumab (LY2951742) With a Long-Term Open-Label Extension in Patients With Chronic Cluster Headache
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of : Galcanezumab (LY2951742) With a Long-Term Open-Label Extension in Patients With Chronic Cluster Headache
Enrollment Status: Completed
Publish Date: August 25, 2020
Intervention Type: Drug
Study Phase: Phase 3
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Cluster Headache
A Phase 3 Randomized, Double-Blind, Placebo-Controlled Study of LY2951742 in Patients With Episodic Cluster Headache
Enrollment Status: Completed
Publish Date: September 09, 2019
Intervention Type: Drug
Study Phase: Phase 3
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
A Non-Invasive Neuromodulation Device for Prevention of Episodic Migraine Headache
Enrollment Status: Terminated
Publish Date: June 19, 2019
Intervention Type: Device
Study Phase: Not Applicable
View 5 Less Clinical Trials

235 Total Publications

Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.
Pharmacologic Treatment for Migraine Prevention in Adults Practice Guideline Recommendations: Report of the AAN Guidelines Subcommittee and the American Headache Society.
Journal: Neurology
Published: August 31, 2026
Similar Doctors
Expertise in
25
conditions
Expertise in
25
conditions
Referral may be required
Before you request

Vickie & Jack Farber Institute For Neuroscience - Honickman Center

1101 Chestnut Street, Floor 10, 
Philadelphia, PA 
 (0.1 miles away)
215-955-1222
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Michael Sperling is a Neurologist practicing medicine in Philadelphia, Pennsylvania. Dr. Sperling is highly rated in 25 conditions, according to our data. His clinical expertise encompasses Seizures, Epilepsy, Generalized Tonic-Clonic Seizure, Absence Seizure, and Deep Brain Stimulation. Dr. Sperling is board certified in Neurology. Dr. Sperling is currently accepting new patients.

Expertise in
20
conditions
Expertise in
20
conditions
Referral may be required
Before you request

Penn Neuroscience Center - Neurology

3400 Civic Center Boulevard, South Pavilion, 2nd Floor, 
Philadelphia, PA 
 (1.8 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients

David Lynch is a Neurologist practicing medicine in Philadelphia, Pennsylvania. Dr. Lynch is highly rated in 20 conditions, according to our data. His clinical expertise encompasses Friedreich Ataxia, Spinocerebellar Ataxia, Drug Induced Dyskinesia, Hereditary Ataxia, and Spinal Fusion. Dr. Lynch is board certified in Neurology, 1993. Dr. Lynch is currently accepting new patients.

Expertise in
48
conditions
Expertise in
48
conditions
Referral may be required
Before you request

Penn Nerve Center University City

3737 Market Street, 7th Floor, 
Philadelphia, PA 
 (2.1 miles away)
800-789-7366
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Lauren Elman is a Neurologist practicing medicine in Philadelphia, Pennsylvania. Dr. Elman is highly rated in 48 conditions, according to our data. Her clinical expertise encompasses Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), Primary Lateral Sclerosis, Myotonic Dystrophy, and Myotonic Dystrophy Type 2. Dr. Elman is board certified in Neurology, 2003. Dr. Elman is currently accepting new patients.

Frequently Asked Questions about Dr. Stephen D. Silberstein

How do I make an appointment with Dr. Stephen D. Silberstein?

You can book an appointment with Dr. Stephen D. Silberstein by calling their office at 215-955-2243. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Stephen D. Silberstein a top-rated expert for Migraine?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Stephen D. Silberstein is classified as an Elite expert for Migraine, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Stephen D. Silberstein specialize in?

While Dr. Stephen D. Silberstein is a Neurology, they have specific expertise in Migraine, Headache, and Cluster Headache. MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Neurology.

Does Dr. Stephen D. Silberstein participate in research or clinical trials?

Yes. Dr. Stephen D. Silberstein has published 235 articles and abstracts on conditions like Migraine. You can view a list of Dr. Stephen D. Silberstein's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Stephen D. Silberstein accept my insurance?

Dr. Stephen D. Silberstein accepts most major insurance plans, including Aetna and Cigna. We recommend calling the office directly at 215-955-2243 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Silberstein's expertise for a condition
ConditionClose
View All 16 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile